LLY: Eli Lilly and Company
2020-09-03 17:12:00
FDA approves additional doses of Trulicity® (dulaglutide) for the treatment of type 2 diabetes
2020-09-03 17:12:00
FDA approves additional doses of Trulicity® (dulaglutide) for the treatment of type 2 diabetes
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.